Stephen J. Forman
2023
In 2023, Stephen J. Forman earned a total compensation of $70.6K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 18% decrease compared to previous year.
Compensation breakdown
| Option Awards | $48,131 |
|---|---|
| Other | $22,500 |
| Total | $70,631 |
Forman received $48.1K in option awards, accounting for 68% of the total pay in 2023.
Forman also received $22.5K in other compensation.
Rankings
In 2023, Stephen J. Forman's compensation ranked 2,908th out of 2,978 executives tracked by ExecPay. In other words, Forman earned more than 2.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,908 out of 2,978 | 2nd |
Division Manufacturing | 1,613 out of 1,637 | 2nd |
Major group Chemicals And Allied Products | 892 out of 906 | 2nd |
Industry group Drugs | 856 out of 869 | 2nd |
Industry Pharmaceutical Preparations | 617 out of 627 | 2nd |
Source: SEC filing on November 4, 2024.
Forman's colleagues
We found four more compensation records of executives who worked with Stephen J. Forman at LIXTE BIOTECHNOLOGY HOLDINGS in 2023.